laurent simon

Name

laurent simon

Legal name

Laurent Simon, Ph.D.

Website

https://laurentsimon.com

Company type

Private

Operating status

Operating

Ownership category

akta.pro rank

Product category

Computational Toxicology Research and PBPK Modeling Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

In Silico / Computational Toxicology & PK/PD Modeling (HLAGAFAM)

akta.pro secondary industries

Clinical Pharmacology & Pharmacometrics (Modeling & Simulation) (HLAIALAG), Cheminformatics & Molecular Modeling / CADD (HLAGAJAE)

Keywords

• PBPK modeling software
• Computational toxicology research
• Dermal absorption modeling
• Pharmacokinetic simulation tools
• Chemical decontamination analysis

Headquarters

HQ city

Newark

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations

Revenue model

1. Research Funding: Primary funding from the Army Research Office for advancing protective science and decontamination strategies through computational toxicology and PBPK modeling. Secondary funding sources from academic and government programs.

Go-to-market motion1 record

Core offering

The Simon research group develops theory-guided computational approaches and software tools for physiologically-based pharmacokinetic (PBPK) modeling, predictive toxicology, and chemical decontamination assessment, primarily funded by the Army Research Office. Deliverables include Mathematica and Python-based PBPK modeling software, hands-on educational laboratory apparatus for pharmacokinetic demonstration, and open-source analytical frameworks for dermal absorption and decontamination window prediction. Research and tools are made available for academic collaboration and to private-sector researchers upon request.

Product overview

Laurent Simon's research group develops computational tools and educational resources for predictive toxicology and pharmacokinetic modeling. The core offerings include PBPK modeling software (Mathematica and Python-based) for dermal absorption prediction and chemical decontamination assessment, complemented by hands-on educational laboratory apparatus demonstrating one- and two-compartment pharmacokinetic models. The group also provides open-source analytical frameworks for determining dermal decontamination windows and publishes scholarly books including 'Control of Biological and Drug-Delivery Systems' and 'Closed-form Solutions for Drug Transport through Controlled-Release Devices in Two and Three Dimensions'. All tools and resources support academic collaboration and are available upon request.

Differentiator

Problem solved

Functional benefit

Products and services

• PBPK Modeling Software Tools Software tools written in Mathematica and Python for building physiologically-based pharmacokinetic (PBPK) models, evaluating decontamination strategies, and predicting dermal absorption of chemical threats. Distributed upon request for collaborative research purposes to academicians and private-sector researchers.
• One-Compartment Pharmacokinetic Model Apparatus Hands-on teaching demonstration using physical apparatus including a peristaltic pump, drug reservoir, plasma compartment, and absorbance measurement system to illustrate one-compartment drug delivery models for high school and undergraduate instructors.
• Two-Compartment Pharmacokinetic Model Apparatus Teaching demonstration showing drug distribution between central and peripheral compartments, extending the single-compartment setup to demonstrate transfer between connected volumes for high school and undergraduate instructors.
• Dermal Decontamination Window Framework Open-source mathematical framework defining the critical time window for effective decontamination by comparing chemical penetration rate with treatment neutralization speed to predict intervention effectiveness for warfare and industrial toxicants.
• VX Skin Penetration and RSDL Neutralization Model Mechanistic skin-decontamination model assessing delayed application of Reactive Skin Decontamination Lotion (RSDL), incorporating diffusion, neutralization, and systemic absorption analysis for nerve agent exposure scenarios.
• Books on Drug Delivery and Controlled-Release Systems Two authored books published with John Wiley & Sons covering drug delivery systems, controlled release technology, and pharmacokinetic modeling for chemical, biomedical, and pharmaceutical engineering applications.

Quantifiable outcome

• Physics-informed neural ODEs outperformed both individual physics-based and AI methods in accurately predicting blood levels at extreme doses
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Army Research OfficecoreStrategic or Co-development PartnerPrimary funding source supporting research to advance protective science and decontamination strategies through computational toxicology and PBPK modeling for chemical threat scenarios.
• Army Educational Outreach Program (AEOP)coreStrategic or Co-development PartnerProvides paid summer internships for eligible students to participate in the Simon group's research in computational toxicology and PBPK modeling.
• NJIT Research Experience for Teachers (RET) and CAMP PHARMA ProgramscoreStrategic or Co-development PartnerCollaborative programs that pair high school teachers and students with faculty mentors in pharmaceutical engineering for classroom activity development.
• American Chemical Society - Project SEED ProgramminorStrategic or Co-development PartnerProgram connecting mentored students with faculty research opportunities in pharmaceutical engineering and computational toxicology.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Certara: Public commercial leader in model-informed drug development, offering Simcyp PBPK platform and biosimulation software widely adopted in pharma. Directly comparable as the dominant commercial counterpart to academic PBPK modeling work, though much broader in scope.
• Simulations Plus: Provider of GastroPlus and other PBPK/pharmacokinetic modeling software used across pharma R&D. Comparable as a commercial PBPK modeling software provider overlapping with the Simon group's core methodological area.
• Schrödinger: Computational chemistry and molecular modeling software company with physics-based simulation platforms used in drug discovery. Comparable in its physics-based modeling approach and PK/decontamination-adjacent chemistry applications, though operating at much larger commercial scale.
• OpenEye / Cadence Molecular Sciences: Molecular modeling and cheminformatics software provider (OpenEye, formerly Cadence). Comparable for its cheminformatics and molecular modeling toolkit overlap with the Simon group's modeling-software deliverables.
• Chemical Computing Group: Developer of the Molecular Operating Environment (MOE) for molecular modeling and cheminformatics. Comparable as a scientific software peer serving computational chemistry and drug-discovery workflows.

Direct peers

• Lhasa Limited: Not-for-profit creating in silico toxicology and chemistry software (Derek Nexus, Meteor, Sarah Nexus). Comparable as a peer organization producing computational tools for predictive toxicology, with similar scientific mission and shared customer segments in pharma and chemical safety.
• Rosa & Co. Specialized PBPK and physiologically-based pharmacokinetic/pharmacodynamic (PBPK/PD) modeling consultancy for pharma. Comparable as a niche-focused commercial PBPK service provider addressing similar drug-delivery and absorption modeling use cases.
• MultiCASE (a Lhasa Limited company): Provider of in silico toxicity prediction software (CASE Ultra) using quantitative structure-activity relationships. Comparable as a computational toxicology software peer with overlapping chemical exposure and risk-assessment customer base.

Emerging players

• Applied BioMath: Model-informed drug development consultancy applying quantitative systems pharmacology and PBPK-style modeling for biotech and pharma clients. Comparable as a focused commercial provider of mathematical modeling services for drug development.
• Insilico Medicine: AI-driven drug discovery company applying generative AI and systems pharmacology to pharmaceutical R&D. Comparable for its intersection of AI/ML with pharmacology and toxicology prediction, though focused on drug discovery rather than chemical threat decontamination.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about laurent simon